GGrantIndex
← Leaderboards

Eva Henriette Gottwein

Duke University

$6,811,349
Attributed
$6,811,349
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,811,349 · 8

By mechanism

R01$5,029,856 · 3
R21$1,192,209 · 3
R00$490,531 · 1
K99$98,753 · 1

Top collaborators

No co-investigators on record.

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Human Herpesvirus 8

Research focus

Human Herpesvirus 8MediatingViralOncogenicMalignant NeoplasmsAcquired Immunodeficiency SyndromeB-LymphocytesGene ExpressionTumorigenesisBaseCellsCell LineRepressionTherapeutic InterventionCell ProliferationPublic HealthInnovationAids Related CancerB-Cell LymphomasNeoplastic CellPrimary Effusion LymphomaExperimental StudyBiologyEffusion

Grant awards (23)

Mechanisms of KSHV-induced endothelial cell loss of contact inhibition of proliferation$472,677
R01 · FY2025 · CA · contact PI
Mechanisms of KSHV-induced endothelial cell loss of contact inhibition of proliferation$537,089
R01 · FY2024 · CA · contact PI
Developing KSHV-Infected Lymphatic Endothelial Cell-Based Models of Kaposi’s Sarcoma$411,400
R21 · FY2024 · CA · contact PI
Transcriptional Control of Cellular Survival and Proliferation in KSHV-transformed B Cells$364,429
R01 · FY2024 · CA · contact PI
Mechanisms of KSHV-induced endothelial cell loss of contact inhibition of proliferation$494,501
R01 · FY2023 · CA · contact PI
Transcriptional Control of Cellular Survival and Proliferation in KSHV-transformed B Cells$364,429
R01 · FY2023 · CA · contact PI
Transcriptional Control of Cellular Survival and Proliferation in KSHV-transformed B Cells$364,429
R01 · FY2022 · CA · contact PI
KSHV-induced oncogenic changes in a primary human lymphatic endothelial cell model of Kaposi's Sarcoma$187,000
R21 · FY2022 · CA · contact PI
Transcriptional Control of Cellular Survival and Proliferation in KSHV-transformed B Cells$13,480
R01 · FY2022 · CA · contact PI
Transcriptional Control of Cellular Survival and Proliferation in KSHV-transformed B Cells$422,820
R01 · FY2021 · CA · contact PI
KSHV-induced oncogenic changes in a primary human lymphatic endothelial cell model of Kaposi's Sarcoma$224,167
R21 · FY2021 · CA · contact PI
Transcriptional Control of Cellular Survival and Proliferation in KSHV-transformed B Cells$344,855
R01 · FY2020 · CA · contact PI
Transcriptional Control of Cellular Survival and Proliferation in KSHV-transformed B Cells$48,207
R01 · FY2020 · CA · contact PI
Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs$320,588
R01 · FY2018 · CA · contact PI
Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs$320,588
R01 · FY2017 · CA · contact PI
Core Essential Genes in Primary Effusion Lymphoma Cell Lines$168,019
R21 · FY2017 · CA · contact PI
Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs$320,588
R01 · FY2016 · CA · contact PI
Core Essential Genes in Primary Effusion Lymphoma Cell Lines$201,623
R21 · FY2016 · CA · contact PI
Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs$320,588
R01 · FY2015 · CA · contact PI
Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs$320,588
R01 · FY2014 · CA · contact PI
Targets and functions of the Kaposi's Sarcoma associated herpesvirus microRNAs$241,531
R00 · FY2012 · CA · contact PI
Targets and functions of the Kaposi's Sarcoma associated herpesvirus microRNAs$249,000
R00 · FY2011 · CA · contact PI
Targets and functions of the Kaposi's Sarcoma associated herpesvirus microRNAs$98,753
K99 · FY2009 · CA · contact PI